• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Introduction to 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid (CAS No. 1249574-57-9)

4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid, with the CAS number 1249574-57-9, is a unique compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrimidine carboxylic acids, which are known for their diverse biological activities and potential therapeutic applications. The structure of 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid includes a pyrimidine ring with specific substitutions that contribute to its unique properties and potential utility in drug development.

The chemical structure of 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid is characterized by a pyrimidine ring with a methyl group at the 4-position and a 2-methylpropyl group at the 2-position, along with a carboxylic acid group at the 5-position. This specific arrangement of functional groups imparts the molecule with distinct physicochemical properties, such as solubility, stability, and reactivity, which are crucial for its potential use in various biological assays and drug discovery processes.

In recent years, pyrimidine derivatives have been extensively studied for their potential as therapeutic agents in various diseases. For instance, pyrimidine carboxylic acids have shown promise in the treatment of cancer, inflammatory diseases, and neurological disorders. The compound 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid has been investigated for its anti-inflammatory properties and its ability to modulate specific enzymes involved in inflammatory pathways. These properties make it a valuable candidate for further research and development in the pharmaceutical industry.

The synthesis of 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid involves several steps, including the formation of the pyrimidine ring and subsequent functionalization to introduce the desired substituents. Various synthetic routes have been explored to optimize yield and purity, ensuring that the final product meets the stringent quality standards required for pharmaceutical applications. One common approach involves the condensation of appropriate precursors followed by selective functional group transformations.

In terms of biological activity, 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid has demonstrated significant potential as an anti-inflammatory agent. Studies have shown that it can effectively inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These cytokines play a crucial role in the pathogenesis of various inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. By modulating these pathways, 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid could potentially offer new therapeutic options for patients suffering from these conditions.

Beyond its anti-inflammatory properties, 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid has also been studied for its potential neuroprotective effects. Research has indicated that this compound can protect neurons from oxidative stress and apoptosis, which are key factors in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The mechanism behind these effects is thought to involve the modulation of intracellular signaling pathways that regulate cell survival and death.

The pharmacokinetic properties of 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid are another important aspect of its evaluation as a potential drug candidate. Studies have shown that it exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. These properties are essential for ensuring that the compound can effectively reach its target tissues and exert its therapeutic effects without causing significant side effects.

Clinical trials are currently underway to further evaluate the safety and efficacy of 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid. Preliminary results from phase I trials have indicated that the compound is well-tolerated by patients at various dose levels. Phase II trials are expected to provide more detailed insights into its therapeutic potential in specific disease indications.

In conclusion, 4-Methyl-2-(2-methylpropyl)pyrimidine-5-carboxylic acid (CAS No. 1249574-57-9) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further research and development in the pharmaceutical industry. As ongoing studies continue to uncover new insights into its mechanisms of action and clinical utility, it is likely that this compound will play an increasingly important role in advancing medical treatments for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)